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Human Cellular Immune Response to Giardia lamblia 
Summary: Human peripheral blood mononuclear cells 
(PBMC) from two individuals experimentally and one 
naturally infected with Giardia lamblia responded 
strongly (in an in vitro lymphocyte proliferation assay) 
to both heterologous and homologous (parasite origin) 
G. lamblia antigen stimuli. Proliferative responses to 
specific antigens as determined by T-cell blotting were 
due to Giardia T-cell epitopes mostly present in 
antigens lower than M r 85,000 and 31,000 in isolates 
PM and GS/M-H7, respectively. Additionally, 11-2 
production of PBMC respective to T lymphocyte 
subsets under antigen stimulation were determined in
one selected patient. Proliferative and lymphokine 
responses could be associated with CD4 ÷ PBMC 
depleted of CD8 ÷ T cells and not with PBMC depleted 
of CD4 ÷ T cells. These preliminary results uggest the 
initiation of larger studies addressing questions of 
cell-mediated immune response and the role of 
lymphokines in human giardiasis. 
Zusammenfassung: ZelluEire Immunreaktion gegen 
Giardia lamblia beim Menschen. Periphere 
Blutmonozyten von zwei Personen mit einer 
experimentell und einer mit einer nattirlich 
erworbenen Giardia lamblia-Infektion zeigten eine 
ausgepr/igte lymphoproliferative Antwort nach 
In-vitro-Stimulation mit Parasitenantigen, das sowohl 
aus homologen als auch heterologen Parasitenisolaten 
gewonnen worden war. Eine T-Zell-Blot- Analyse der 
lymphoproliferativen Immunantwort beziiglich der nach 
Molekulargewicht aufgetrennten Giardia-Antigen- 
komponenten zeigte, dab das Spektrum der Giardia- 
Antigene mit T-Zell-Epitopen im Mr-Bereich von 
< 85'000 ffir das PM-l-Isolat und < 31'000 fiir das 
GS/M-H7-Isolat lagen. Bei einem der Patienten wurden 
Lymphozyten ach antigen-spezifischer In-vitro-Pro- 
liferation auf ihre Lymphozytensubpopulationen u d 
deren F/ihigkeit zur I1-2-Produktion untersucht. Eine 
lymphoproliferative Antwort, verkoppelt mit einer 
I1-2-Produktion, war nur bei CD4 + Lymphozyten ( ach 
entsprechender Eliminierung yon CD8 ÷ Lymphozyten) 
und nicht bei CD8 + Lymphozyten ( ach entsprechender 
Eliminierung von CD4 + Lymphozyten) achweisbar. 
Introduction 
Giardia lamblia is a protozoan parasite which resides in 
the small intestines of humans and other mammals. 
Disease manifestations vary from asymptomatic carriage 
to severe diarrhea and malabsorption. Although the 
natural history of Giardia infections i  not well described, 
it is known that some persons elf-cure, suggesting the
development of immunity or resistance, while others 
develop long-standing chronic infections [1-3]. In humans 
the importance of the immune system is implied by the 
increased susceptibility to infection and/or in difficulty 
with eradiction of infections in patients with 
hypogammaglobulinemia or X-linked immunoglobulin 
deficiency [4]. 
Although both cellular and humoral immune responses 
have been studied in Giardia muris infections in the mouse 
and suggest the importance of both humoral and cellular 
mechanisms in the development of protective immunity or 
resistance to infection [5], there are few studies which 
suggest the importance of the cellular immune response in 
humans [1,3,6]. Increased mucosal and intra-epithelial 
lymphocytes are found in the intestines of humans and in 
vitro studies indicate that phagocytes can ingest opsonized 
or damaged G. lamblia. There is little or no information 
the parasite-specific T- ell immune response to G. lamblia 
in humans, despite the idea that the interaction between 
G. lamblia and the cellular immune mechanisms may be 
important in parasite clearance and in the development of 
protective immunity as well as contributing to mucosal 
damage after specific T-cell activation in response to G. 
lamblia infection [3]. Therefore, we have begun to analyze 
the status of parasite-specific lymphocytes in peripheral 
blood of patients with naturally or experimentally 
acquired giardiasis. Although based on a restricted 
number of investigated patients, our preliminary eport 
suggests that human peripheral T lymphocytes from 
exposed individuals exhibit a marked lymphoproliferative 
response to stimulation with a wide range of G. lamblia 
antigenic polypeptides. This cellular immune response 
includes 11-2 synthesis by CD4 ÷ cells following stimulation 
with Giardia and other control antigens. 
Patients and Methods 
Experimental design: Cellular immune responses to G. lamblia 
antigens were determined by lymphocyte proliferation assays to 
both heterologous and homologous parasite isolates in tw  se s 
of infected individuals. Later, proliferation to specific antigens 
was determined by T- cell blotting. Additionally, I1-2 synthesis 
and the T lymphocyte subsets producing I1-2 under antigen 
stimulation were determined in one selected patient. 
Patients and control donors: Peripheral blood mononuelear cells 
(PBMC) were obtained from the following donors: (i) two 
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Table 1 : Proliferative response of human PBMC to Giardia lamblia ntigens. 
Control individuals 
MZ 102 304 (3.0) 48 (0.5) 114 (1.1) 25,955 
IC 349 129 (0.4) 349 (1.0) 984 (2.8) 50,369 
MM 1,426 4,325 (3.0) 3,087 (2.1) 3,779 (2.6) 31,887 
Infected individuals 
PM* 595 29,286 (49.2) 23,061 (38.8) 35,748 (60.1) 31,299 
GS** 665 53,705 (80.8) 28,061 (42.2) 36,520 (54.9) 28,560 
"Wea .. . . .  987 14,700 (14.9) 6,460 (6.5) 7,420 (7.5) 31,682 
* Cells obtained 2months after natural infection. 
** Cells obtained 6years after natural infection. 
*** Cells obtained 2years after experimental voluntary infection 
(treated 3 weeks post inoculation). 
SI: considered significantly positive when > 3.0. 
patients (GS and PM) with coproscopically proven, naturally 
acquired symptomatic G. lamblia infection. Both adult male 
patients were residents of the Washington D.C. area. Time 
intervals between infection and blood sampling was six years for 
GS and two months for PM. GS acquired his infection in Alaska, 
while PM most likely acquired his infection in the Washington 
D.C. area (patients PM and GS provided the parasite isolates 
PM and GS, respectively; the latter was cloned and one clone, 
GS/M-H7, was subsequently used to infect the normal volunteer 
"Wea"); (ii) an adult volunteer ("Wea") participated in a 
previously described study [7]. The volunteer was experimentally 
inoculated with the G. lamblia clone GS/M-H7; he became 
infected and was treated three weeks post inoculation. The 
infected volunteer's characteristics have been reported [8]. 
Blood was obtained two years later. Serum from each of the 
patients was positive for IgG anti-G, larnblia antibodies by 
ELISA [9] two weeks after infection, but was negative at the time 
of blood sampling for the present study; (iii) three control 
persons (MZ, IC, MM) with no history of giardiasis or symptoms 
suggestive of giardiasis for the preceding six years. They denied 
current illness, prolonged or undiagnosed diarrhea, and travel to 
countries with low hygienic standards. MZ (female) and IC 
(female) were both from Switzerland, MM (male) was from the 
Washington D.C. area. All control persons were negative for IgG 
anti-G, lamblia antibodies by ELISA. 
Giardia lamblia: The G. lamblia GS/M-H7 clone [10] originated 
from the patient GS described above, the G. lamblia isolate 
PM-1 and WEA from the patient PM and "Wea", respectively. 
The G. larnblia isolate WEA represented an isolate derived from 
clone GS/M-H7 after isolation from the experimentally infected 
volunteer "Wea". The G. lamblia clone GS/M- H7 and isolates 
PM-1 and WEA were cultivated in TYI-S-33 medium with 
antibiotics as previously reported [11]. Soluble G. lamblia 
trophozoite antigens for use in SDS-PAGE and in stimulation of 
a lymphoproliferative in vitro response were obtained by 
following exactly the procedure published elsewhere [i2]. 
Isolation of cells: PBMC were obtained by sedimentation of 
heparinized peripheral venous blood on Ficoll-Hypaque 
(following the manufacturer's instructions, Pharmacia Fine 
Chem.), washed twice in Hank's balanced salt solution (HBSS), 
once in tissue culture medium (TCM: RPMI 1640 containing 
10% human AB+ serum, 12 mM HEPES buffer, and a 
supplement of L-glutamine [2mM], penicillin [100 units/ml], 
streptomycin [100 ~g/ml] and fungizone [0.25 ~tm/ml]). A portion 
of the cells was diluted 1:1 with freezing medium (50% human 
AB + serum and 25% DMSA in TCM as described above) and 
cryopreserved for supply of feeder cells in some experiments. 
In vitro lymphocyte proliferation assay: A previously described 
procedure was employed [12] with the following modifications. 
Cells were suspended at a concentration of 1.0xl06 per ml and 
tested at 2x105 cells per U-bottomed well. All tests were 
performed in triplicate. Phytohemagglutinin (PHA) stimulation 
(1.25 lxg PHA per ml) was used as an internal control and PHA 
was added to the corresponding control wells three days prior to 
harvesting. Cells were harvested on the sixth day of antigen 
stimulation and/or in vitro cultivation. Results are expressed as 
mean counts per min (a standard eviation of 20% with respect 
to the mean cpm was usual) and as stimulation index (SI: mean 
cpm in experimental wells/mean cpm in medium control wells). 
II-2-production: PBMC 'from one selected, highly responsive G. 
lamblia patient (GS) and from one control person (MZ) were 
tested for in vitro production of I1-2 following stimulation with G. 
lamblia antigen, as well as with the control antigens influenza A 
virus (FLU), HLA aUoantigens [using a pool of 5000 rad 
irradiated PBMC from three unrelated donors] (ALLO), and 
PHA. Negative control cultures were unstimulated and 
contained only media (MED). Cultures used for 11-2 production 
contained the human anti- 11-2 receptor monoclonal antibody, 
anti-Tac, to block 11-2 consumption by the activated T cells [13]. 
The additional control panel of stimuli was selected for study 
because T helper cell (TH) responses to FLU have been recently 
shown to be MHC self-restricted and require CD4 ÷ T H and 
autologous antigen-presenting cells. In contrast, the T H 
responses to ALLO and PHA can utilize both CD4 ÷ and CD8 + 
TH [13]. We followed previously established procedures [13] but 
also included G. lamblia antigens which were employed at the 
concentration mentioned above [12]. After seven days of 
incubation, culture supernatants were collected and frozen at 
-20°C. The supernatant 11-2 activity was assessed by the ability to 
stimulate the proliferation of the I1-2-dependent cell line CTLL 
Assay cultures consisted of 8x103 CTLL/well and five successive 
2-fold dilutions of supernatant. Results are expressed asmean 
cpm for test and control wells. Standard deviations were 
maximally 10% with respect o the mean cpm. 
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Figure 1: Lymphoproliferative r sponses of a patient with a 
past Giardia lamblia infection: Unfractionated PBMC (left); 
PBMC depleted of CD8 ÷ cells and supplemented with (5000 
rad irradiated) autologous PBMC as source of accessory cells 
(middle); and PBMC depleted of CD4 + cel ls and 
supplemented with (5000 rad irradiated) autologous PBMC as 
source of accessory cells (right). The PBMC of patient GS were 
unstimulated (MED); or were stimulated with influenza A virus 
(FLU); 5000 rad irradiated allogenic PBMC (ALLO); or Giardia 
lamblia (GS/M-H7 clone) trophozoite antigen, Standard errors 
of the means are indicated. 
ll-2-determination for CD4 + or CD8 + cells: PBMC from GS were 
depleted of CD4 + or CD8 + T cells as described previously [13]. 
Briefly, CD4 ÷ and CD8 ÷ T cells were negatively selected by a 
panning technique in which PBMC were incubated with 
anti-CD4 (Leu 3a) murine MAb (Becton Dickinson, Mountain 
View, CA). The cells were then washed and incubated for 2 h at 
room temperature in petri dishes coated with the IgG fraction of 
goat anti-mouse antibody (Cappel, CochranviUe, PA). 
Non-adherent cells were collected and adjusted to the desired 
concentrations. These panning techniques permitted 95% 
depletion as defined by flow cytometry [13]. The subsets were 
assessed for II-2-production after antigen stimulation and 
addition of irradiated autologous PBMC (RC) as an additional 
source of antigen presenting cells. 
T-cell blotting: Profiles of PBMC responses to SDS-PAGE 
resolved, solid-phase (Immobilon ®) G. larnblia trophozoite 
antigens were determined by T-cell blotting according to the 
procedure described previously [12]. PBMC were tested at a 
concentration f 6x105 cells per microwell. Cells were harvested 
on the seventh day of antigen stimulation. The results are 
expressed as the change in counts per min (/k cpm; mean ct/min 
in experimental wells - mean ct/min in control wells) or as 
stimulation index (SI). A maximal standard eviation of 35% 
with respect o the mean cpm was acceptable [14]. 
Results 
In Vitro PBMC Proliferative Response 
PBMC obtained from naturally or experimentally infected 
patients with giardiasis and control donors were tested for 
their proliferative response to G. lamblia trophozoite 
antigen preparations derived from the GS/M-H7 clone 
and from the PM-1 and WEA isolates (Table 1). All 
patients showed significant proliferation to all three 
isolates. The two naturally infected patients (GS and PM) 
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SUPERNATANT DILUTIONS 
Figure 2:11-2 titration curves generated by PBMC from patient 
GS without stimulation (+); or stimulated with FLU (~), ALLO 
(r-I) or Giardia lamblia (GS/M-H7 clone) trophozoite antigen 
(O). The culture supernatants generated in the cultures were 
diluted through for 2-fold dilutions (1:4 - 1:32) and tested for 
11-2 activity on the 11-2 dependent CTLL cell line. Unfractionated 
PBMC are shown in the upper panel A; PBMC depleted of 
CD8 + cells in the middle panel B; and PBMC depleted of CD4 + 
cells in the lower panel C. 
homologous infecting parasite isolates/clone and (ii) 
markedly higher cpm in comparison to the experimentally 
infected individual ("Wea"). The volunteer "Wea" had 
higher SI following stimulation with antigens from the 
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Giardia lamblia: Profile of lymphocyte proliferative r sponse in T-cell blotting 
Antigen: GS/M-H7 isolate 
PM-PBMC 
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Figure 3: Profile of proliferative responses of PBMC from two (PM and GS) giardiasis patients to stimulation with Giardia larnblia 
antigens derived from the homologous or heterologous infection parasite isolate. The immunoblots consisted of continuous 
fractions with the M r indicated on the horizontal axis. The numbers on the side of the columns indicate the SI of the respective 
fraction. Blank discs without antigen were run in parallel as a negative control (data not shown). 
parasite clone (GS/M-H7) which had been used for 
inoculation in comparison to heterologous isolates. 
Giardia Antigen-Induced Proliferation and II-2-Production 
by T-Cell Subsets 
Unfractionated aswell as CD8- and CD4-depleted PBMC 
from patient GS were retested (six and a half years after 
infection) by proliferation and 11-2 production i  response 
to stimulation with G. lamblia (GS/M-H7 clone) 
trophozoite antigen. In this experiment we also tested the 
r6sponses of these PBMC to unrelated influenza A virus 
(FLU) and HLA alloantigens (ALLO), non-Giardia 
antigens to which this patient previously had been shown 
to be responsive. These two stimuli also served as controls 
in this experiment, because it had been previously 
demonstrated that the TH response to FLU by human 
PBMC is dependent on CD4 + T cells, whereas TH activity 
to ALLO can be mediated by both CD4 + and CD8 + 
lymphocytes [13]. 
The proliferative responses are shown in Figure 1. 
Unfractionated PBMC generated strong proliferative 
response to all three antigen stimuli. The response to G. 
lamblia (GS/M-H7 clone) trophozoite antigen was 
stronger than to FLU and almost as strong as to ALLO. 
PBMC depleted of CD8 + cells (CD4 + sAPC) were 
responsive to all three stimuli. The unstimulated cultures 
from this group also exhibited elevated proliferative 
activity, possibly reflecting an autologous mixed 
lymphocyte reaction. Nevertheless, the response by 
unstimulated CD8-depleted PBMC was at least 10-fold 
below the responses of the stimulated cultures. In contrast 
to the unfractionated and CD8-depleted groups, PBMC 
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depleted of CD4 ÷ cells (CD8 ÷ sAPC) responded to 
ALLO but not to FLU or G. lamblia (GS/M-H7 clone) 
trophozoite antigen. 
The 11-2 titration curves in response to FLU, G. lambtia 
(GS/M-H7 clone) trophozoite antigen and ALLO are 
plotted in Figure 2. Unfractionated PBMC (upper panel) 
generated strong responses to all three stimuli. The 
responses to FLU and G. lamblia (GS/M-H7 clone) 
trophozoite antigen were equivalent and somewhat 
weaker than the response to ALLO. PBMC depleted of 
CD8 ÷ cells (middle panel) were strongly responsive to all 
three stimuli, and the responses to FLU and G. lamblia 
(GS/M-H7 clone) trophozoite antigen were elevated 
compared to the responses by unfractionated PBMC. In 
contrast, the 11-2 responses of CD4-depleted PBMC 
(lower panel) were near background (unstimulated) 
levels, whereas 11-2 production to ALLO was strong, 
although somewhat reduced compared to the ALLO 
response by unfractionated or CD8-depleted PBMC. 
Thus, the data in Figures 1 and 2 demonstrated that the 
T H response to G. lamblia (GS/M-H7 clone) trophozoite 
antigen is mediated by CD4 ÷ T cells but not by CD8 ÷ T 
cells. It is noteworthy that potent Tn immunity is retained 
for more than six years after primary infection without any 
known subsequent exposure to G. lamblia. 
T-Cell Blotting 
Unfractionated PBMC were tested by T-cell blotting for 
their proliferative response to SDS-PAGE resolved 
solid-phase G. lamblia trophozoite antigens from 
homologous and heterologous infecting parasite 
isolate/clone. Figure 3 shows the results obtained with 
PBMC from patients PM and GS, respectively. PBMC 
from a negative control person (MZ) showed no 
significant SI>2 over the complete depicted range of the 
relative molecular mass, Mr (data not shown). The 
patterns of lymphoproliferative responses of GS and PM 
PBMC were generally similar with respect to both 
antigens GS/M-H7 and PM-1, although some differences 
were noted among the some Mr groupings: For the two 
patients a group of Mr polypeptides smaller than 85,000 
(PM-l-antigen) and 31,000 (GS/M-H7-antigen) 
stimulated significant proliferative responses. The 
PM-l-antigen generally appeared to be a stronger 
stimulus (= higher average counts and wider M r range) 
than the GS/M-H7-antigen. The PM-l-antigen also 
resulted in increased SI with homologous (PM) than with 
heterologous (GS) PBMC. This difference was not 
observed with GS/M-H7-antigen. 
Discussion 
Specific cellular immune responses to G. lamblia and, in 
particular, to individual resolved parasite antigens have 
either not been reported, or have only rarely been 
observed. The present study of lymphocyte proliferative 
response was performed using peripheral blood 
teukocytes. Proliferation was stimulated by both soluble 
antigens from homologous infecting isolates and 
heterologous G. lamblia isolates originating from 
geographically disparate areas. However, there was a 
tendency to exhibit higher stimulation indices with the 
homologous parasite antigen. Cells from patients with 
naturally acquired infection generally showed much 
stronger proliferation than those from the experimentally 
infected person. This appears plausible due to the 
interruption of infection by chemotherapy three weeks 
post inoculation, and due to the mild symptoms observed 
in the voluntarily infected person. In contrast, there were 
prolonged and marked symptoms for both naturally 
infected patients. T-ceU blotting revealed substantial 
lymphoproliferative r sponses over a relative wide Mr 
(relative molecular mass) range in two naturally infected 
patients, although this response was restricted to 
molecules with M r < 85,000. This contrasts with a 
previously published study with similar objectives but 
employing a mouse model for G. lamblia [12], where the 
M r range of polypeptides with T-cell epitopes included 
larger molecules with a dominance at 100-200,000. 
Remarkable is the lack of a lymphoproliferative response 
to antigens of the Mr 72,000 area of the GS/M-H7-antigen. 
This area corresponds to the migration site of the "major 
surface epitope" of the respective clone [12] and was 
already characterized by the absence of a lympho- 
proliferative response in a mouse model [12]. 
Analysis of parasite-specific lymphoproliferative response 
and 11-2 production revealed that peripheral cellular and 
lymphokine reactivity were both dependent on CD4 ÷ T 
cells (= PBMC depleted of CD8 ÷ T cells). 
The role of such cells is unclear, but our results indi- 
cate that they maintain a perpetually disseminated 
parasite-specific memory. This cell-mediated immune 
response may initially have assisted the induction of 
(local) humeral immune response. Since there are 
indications that protective immunity may be acquired [3], 
and that this and the primary eradiction of Giardia from 
the intestine is dependent on both humeral and cellular 
responses [15,16], the observed systemic immune response 
may also reflect an active immunological role and history 
at the site of infection by direct lymphocyte-parasite 
interaction. The patients investigated in the present study 
lacked parasite-specific serum antibodies for two to six 
years following infection. In contrast, they showed 
Giardia-specific lymphoproliferative and lymphokine 
responses. Many of the basic questions concerning the role 
and potential effector mechanisms of immune 
lymphocytes in clearance of infection and protective 
immunity remain unanswered. The demonstration of 
long-lasting cell-mediated immunity (for at least six years) 
to Giardia-antigen raises the possibility of initiating 
appropriate studies with respect o: (a) local intestinal, 
humeral and cellular immune responses in human 
giardiasis patients; (b) participation of cellular immune 
response in generating protective immunity to reinfection; 
and (c) consideration of strategies for developing a 
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prophylactic vaccine against G. lambtia. Protective 
immunity may be highly dependent upon and thus limited 
by antigenic differences observed within [17] and between 
various parasite isolates [18]. The strategies for developing 
a vaccine are suggested by the long-term Tn cell memory 
observed in the present investigation. 
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